Literature DB >> 18339857

The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.

Beryl A Hatton1, Elisabeth H Villavicencio, Karen D Tsuchiya, Joel I Pritchard, Sally Ditzler, Barbara Pullar, Stacey Hansen, Sue E Knoblaugh, Donghoon Lee, Charles G Eberhart, Andrew R Hallahan, James M Olson.   

Abstract

Toward the goal of generating a mouse medulloblastoma model with increased tumor incidence, we developed a homozygous version of our ND2:SmoA1 model. Medulloblastomas form in 94% of homozygous Smo/Smo mice by 2 months of age. Tumor formation is, thus, predictable by age, before the symptomatic appearance of larger lesions. This high incidence and early onset of tumors is ideal for preclinical studies because mice can be enrolled before symptom onset and with a greater latency period before late-stage disease. Smo/Smo tumors also display leptomeningeal dissemination of neoplastic cells to the brain and spine, which occurs in many human cases. Despite an extended proliferation of granule neuron precursors (GNP) in the postnatal external granular layer (EGL), the internal granular layer formed normally in Smo/Smo mice and tumor formation occurred only in localized foci on the superficial surface of the molecular layer. Thus, tumor formation is not simply the result of over proliferation of GNPs within the EGL. Moreover, Smo/Smo medulloblastomas were transplantable and serially passaged in vivo, demonstrating the aggressiveness of tumor cells and their transformation beyond a hyperplastic state. The Smo/Smo model is the first mouse medulloblastoma model to show leptomeningeal spread. The adherence to human pathology, high incidence, and early onset of tumors thus make Smo/Smo mice an efficient model for preclinical studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339857     DOI: 10.1158/0008-5472.CAN-07-5092

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  101 in total

1.  Basal cell carcinomas in mice arise from hair follicle stem cells and multiple epithelial progenitor populations.

Authors:  Marina Grachtchouk; Joanna Pero; Steven H Yang; Alexandre N Ermilov; L Evan Michael; Aiqin Wang; Dawn Wilbert; Rajiv M Patel; Jennifer Ferris; James Diener; Mary Allen; Seokchun Lim; Li-Jyun Syu; Monique Verhaegen; Andrzej A Dlugosz
Journal:  J Clin Invest       Date:  2011-04-25       Impact factor: 14.808

2.  Notch signaling is not essential in sonic hedgehog-activated medulloblastoma.

Authors:  B A Hatton; E H Villavicencio; J Pritchard; M LeBlanc; S Hansen; M Ulrich; S Ditzler; B Pullar; M R Stroud; J M Olson
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

3.  An essential role for p38 MAPK in cerebellar granule neuron precursor proliferation.

Authors:  Cemile G Guldal; Adiba Ahmad; Andrey Korshunov; Massimo Squatrito; Aashir Awan; Lori A Mainwaring; Bipin Bhatia; Susana R Parathath; Zaher Nahle; Stefan Pfister; Anna M Kenney
Journal:  Acta Neuropathol       Date:  2012-04       Impact factor: 17.088

Review 4.  Sonic hedgehog patterning during cerebellar development.

Authors:  Annarita De Luca; Valentina Cerrato; Elisa Fucà; Elena Parmigiani; Annalisa Buffo; Ketty Leto
Journal:  Cell Mol Life Sci       Date:  2015-10-24       Impact factor: 9.261

Review 5.  Genetic and molecular alterations across medulloblastoma subgroups.

Authors:  Patryk Skowron; Vijay Ramaswamy; Michael D Taylor
Journal:  J Mol Med (Berl)       Date:  2015-09-09       Impact factor: 4.599

6.  Kif3a is necessary for initiation and maintenance of medulloblastoma.

Authors:  Monique T Barakat; Eric W Humke; Matthew P Scott
Journal:  Carcinogenesis       Date:  2013-02-06       Impact factor: 4.944

Review 7.  Medulloblastoma development: tumor biology informs treatment decisions.

Authors:  Vidya Gopalakrishnan; Rong-Hua Tao; Tara Dobson; William Brugmann; Soumen Khatua
Journal:  CNS Oncol       Date:  2015

8.  MyoD is a tumor suppressor gene in medulloblastoma.

Authors:  Joyoti Dey; Adrian M Dubuc; Kyle D Pedro; Derek Thirstrup; Brig Mecham; Paul A Northcott; Xiaochong Wu; David Shih; Stephen J Tapscott; Michael LeBlanc; Michael D Taylor; James M Olson
Journal:  Cancer Res       Date:  2013-10-03       Impact factor: 12.701

9.  A CK1α Activator Penetrates the Brain and Shows Efficacy Against Drug-resistant Metastatic Medulloblastoma.

Authors:  Jezabel Rodriguez-Blanco; Bin Li; Jun Long; Chen Shen; Fan Yang; Darren Orton; Sara Collins; Noriyuki Kasahara; Nagi G Ayad; Heather J McCrea; Martine F Roussel; William A Weiss; Anthony J Capobianco; David J Robbins
Journal:  Clin Cancer Res       Date:  2018-11-28       Impact factor: 12.531

10.  Two tumor suppressors, p27Kip1 and patched-1, collaborate to prevent medulloblastoma.

Authors:  Olivier Ayrault; Frederique Zindy; Jerold Rehg; Charles J Sherr; Martine F Roussel
Journal:  Mol Cancer Res       Date:  2009-01       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.